Pharmacokinetics
Cmax and Tmax Profiles Across Subcutaneous, Intravenous, and Intranasal Routes
How different injection routes reshape peak drug levels and timing for clinical effect.
Marcus Tully-Byrne
· 11 min read
Route of Administration — Page 3
Accelerated Stability Testing Protocols for Peptide Drug Products
A map of four chemical degradation pathways guides stability study design for peptides.
Marcus Tully-Byrne
Nose-to-Brain Transport Mechanisms for Peptide Therapeutics
Nasal delivery bypasses the blood-brain barrier through direct neural pathways.
Priya Venkatesan
Proteolytic Barriers at the Nasal Mucosa for Peptide Therapeutics
Enzymes in the nasal lining degrade peptides before they reach circulation or the brain.
Séverine Okafor
Nanoparticle Encapsulation as a Peptide Stability Strategy
Nanoparticles shield peptides from degradation and control when they reach their targets.
Marcus Tully-Byrne